Stock listing
Gri Bio, Inc.
Selected listing: GRI · NASDAQ · USD · US
Gri Bio, Inc. (NASDAQ:GRI), Health Technology. Latest release Sep 28, 2026: GRI Bio to Highlight Immune Modulation and Phase 2a Development Insights in IPF…
- Ticker
- NASDAQ:GRI
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Gri Bio, Inc.
Gri Bio, Inc. is a public company traded under the ticker GRI in the American market. Gri Bio focuses on developing innovative solutions in its field, contributing to advancements in biotechnology.
Latest news from Gri Bio, Inc.
GRI Bio to Highlight Immune Modulation and Phase 2a Development Insights in IPF at the 10th IPF Summit
September 28, 2026
GRI Bio Featured in "Why Now" On-Demand Video Webcast
August 27, 2026
GRI Bio to Present Late-Breaking Phase 2a GRI-0621 Data Highlighting Lung Function, Anti-Fibrotic Biomarkers and Favorable Tolerability in IPF at ERS 2026
August 24, 2026
GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis
June 18, 2026
GRI Bio to Present at A.G.P.’s Annual Healthcare Company Showcase
May 18, 2026